NDC 13668-0014 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13668-0014
- Manufacturer
- Rebel Distributors Corp
- Effective date
- 2010-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - Rebel Distributors Corp | Rebel Distributors Corp | 2010-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | Advanced Rx of Tennessee, LLC | 45a07f44-078d-0513-e063-6394a90a1629 | 2025-12-10 | Warnings, Adverse reactions | 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Advanced Rx of Tennessee, LLC | 45a03a43-04db-9138-e063-6394a90a12fa | 2025-12-10 | Warnings, Adverse reactions | 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Guardian Drug Company | e77162ff-0ff9-45ca-95fc-da6ea24ce5a2 | 2025-12-02 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam Extended-Release | LEVETIRACETAM | Golden State Medical Supply, Inc. | 5dde1889-a217-4493-9a71-9fd39ed04630 | 2025-11-24 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 6e31e766-6504-4f20-8831-1953363cace0 | 2025-11-21 | Warnings, Adverse reactions | 311290 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hp Halden Pharma AS | 1d9abcce-8ef7-422b-bf4b-5835bf4dbb34 | 2025-11-21 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hp Halden Pharma AS | 6951de41-4a16-4cca-8039-44fc81407081 | 2025-11-21 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hp Halden Pharma AS | 35bb1e5f-d5cd-4e7f-a056-48c0cf9ebd76 | 2025-11-21 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 01aef7f7-6092-4e39-8451-dc02d8db9254 | 2025-11-21 | Warnings, Adverse reactions | 311288 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Baxter Healthcare Corporation | 8e381590-1147-46f3-9cbd-dc9716013444 | 2025-11-20 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 58ed7049-44c6-4f97-9174-c0e1504586a6 | 2025-11-19 | Warnings, Adverse reactions | 387003 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 5eb7bea5-c95f-4a38-a5bb-c20d1549c797 | 2025-11-19 | Warnings, Adverse reactions | 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | bc12f0b0-e05c-48e4-ad08-0ff14a818a64 | 2025-11-19 | Warnings, Adverse reactions | 387003 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 43df4156-0958-e496-e063-6294a90a5329 | 2025-11-18 | Warnings, Adverse reactions | 311290 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | b9597cd5-5745-494a-bd72-93071ed221da | 2025-11-18 | Warnings, Adverse reactions | 387003 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Mylan Institutional Inc. | 08e1bfea-7f3f-42d9-823d-f75080e664ff | 2025-11-12 | Warnings, Adverse reactions | 311289 44YRR34555 |
| LEVETIRACETAM solution | LEVETIRACETAM | Chartwell Governmental & Specialty RX, LLC. | e1ebd960-79a4-4632-b727-4e9811824113 | 2025-11-11 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Eugia US LLC | 3e43c17f-7e7e-4ccd-b321-1dd5e62cdafd | 2025-11-11 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | TAGI Pharma, Inc. | 72f7ddd9-1b2c-4e26-8060-20e10c1c5d1c | 2025-11-04 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Lupin Pharmaceuticals, Inc. | 18648f51-a37c-41e1-b451-123bc0cf5446 | 2025-10-30 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.